Received Feb 12, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
past the 6-month timeframe for the 2nd Shingrix dose.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (Received 1st dose on an unknown date). On an unknown date, the patient did not received the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: past the 6-month timeframe for the 2nd Shingrix dose.). The outcome of the incomplete course of vaccination was unknown. Additional Information: GSK Receipt Date: 04-FEB-2025 The pharmacist enquired, If it has been more than 6 months does the series need to be restarted for Shingrix vaccine. The pharmacist confirmed with the Health Care Professional that the patient was past the 6-month timeframe for the 2nd dose of Shingrix. The Vaccine Administration Facility is the same as Primary Reporter. As the patient did not receive the second dose of vaccine within the recommended timeframe, which led to incomplete course of vaccination